Imaging of melanoma: Accuracy of ultrasonography before and after contrast injection for diagnostic and early evaluation of treatments;Imagerie des mélanomes: Performances de l'échographie sans et avec injection de produit de contraste pour le diagnostic et l'évaluation des traitements

Bulletin du Cancer

Volumn 94, Issue 1, 2007, Pages 93-98

  Lassau, Nathalie ^a   Chami, Linda ^a   Peronneau, Pierre ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Dynamic contrast enhanced ultrasonography; Melanoma; Neovascularisazation; Quantification; Treatment evaluation

Indexed keywords

BRACCO; CONTRAST MEDIUM; SHU 508; SONOVUE; UNCLASSIFIED DRUG;

CANCER RECURRENCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FOLLOW UP; HUMAN; IMAGING SYSTEM; LIMB PERFUSION; MELANOMA; OUTCOME ASSESSMENT; REVIEW;

CONTRAST MEDIA; HUMANS; MELANOMA; MONITORING, PHYSIOLOGIC; PHOSPHOLIPIDS; POLYSACCHARIDES; PROGNOSIS; SKIN NEOPLASMS; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY;

EID: 33846912072     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2007.0186     Document Type: Review

References (26)

1. Kraus W, Schramm P, Hoede N. First experiences with a high resolution ultrasonic scanner in the diagnosis of malignant melanomas. Arch Dermatol Res 1983 ; 275 : 235-8.
2. Dines K, Sheets P, Bink J, Hank CW, Condra KA, Clendenon JL, et al. High-frequency ultrasonic imaging of skin : experimental results. Ultrasound Imaging 1984 ; 6 : 408-34.
3. Hoffman K, Jung J, El Gammal S, Altmeyer P. Malignant melanoma in 20-MHz B scan US. Dermatology 1992 ; 185 : 49-55.
4. Fornage B, McGavran M, Duvic M, Waldron C. Imaging of the skin with 20 MHz sonography. Radiology 1993 ; 189 : 69-79.
5. Harland C, Kale S, Jackson P, Mortimer P, Bamber J. Differentiation of common benign pigmented skin lesions from melanoma by high-resolution ultrasound. Br J Dermatol 2000 ; 143 : 281-9.
6. Bessoud B, Lassau N, Koscielny S, Longvert C, Avril MF, Duvillard P, et al. High-frequency sonography and color Doppler in the management of pigmented skin lesions. Ultrasound in Med 2003 ; 29 : 875-9.
7. Lassau N, Spatz A, Avril MF, Tardivon A, Margulis A, Mamelle G, et al. Value of high-frequency US for preoperative assessment of skin tumors. Radiographics 1997 ; 17 : 1559-65.
8. Harland C, Bamber JC, Gusterson B, Mortimer P. High-frequency, high resolution B-scan ultrasound in the assessment of skin tumours. Br J Dermatol 1993 ; 128 : 525-32.
9. Lassau N, Mercier S, Koscielny S, Avril MF, Margulis A, Mamelle G, et al. Prognostic value of high-frequency sonography for the preoperative assessment of melanomas. Am J Roentgenol 1999 ; 172 : 457-61.
10. Lassau N, Paturel-Asselin C, Guinebretiere JM, Leclere J, Koscielny S, Roche A, et al. New hemodynamic approach to angiogenesis : color and pulsed Doppler ultrasonography. Invest Radiol 1999 ; 34 : 194-8.
11. Srisvastava A, Hughes L, Woodcock J, Laidler P. Vascularity in cutaneous melanoma detected by Doppler sonography and histology : correlation with tumor behaviour. Br J Cancer 1989 ; 59 : 89-91.
12. Giovagnorio F, Andreoli C, De Cicco ML. Color Doppler sonography of focal lesions of the skin and subcutaneous tissue. J Ultrasound Med 1999 ; 18 : 89-93.
13. Lassau N, Koscielny S, Avril MF, Margulis A, Duvillard P, De Baere T, et al. Prognostic value of angiogenesis evaluated with high-frequency and color Doppler sonography for preoperative assessment of melanomas. Am J Roentgenol 2002 ; 178 : 1547-51.
14. Lassau N, Lamuraglia M, Koscielny S, Spatz A, Roche A, Leclère J, et al. Prognostic value of angiogenesis evaluated with high-frequency and colour Doppler sonography for preoperative assessment of primary cutaneous melanomas : correlation with recurrence after a 5 year follow-up period. Cancer Imaging 2006 ; 25 : 24-9.
15. Barnhill RL, Levy MA. Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis. Am J Pathol 1993 ; 143 : 99-104.
16. Straume O, Akslen LA. Expression of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. Am J Pathol 2001 ; 159 : 223-35.
17. Lassau N, Chami L. Imagerie et angiogenèse : la DCE-US. Bull Cancer (in press).
18. Assalin-Paturel C, Lassau N, Guinebretière JM, Zhang J, Gay F, Bex F, et al. Transfer of the murine interleukin-12 gene in vivo by the Semliki forest virus induces B16 tumour regression through inhibition of tumour blood vessel formation monitored by Doppler ultrasonography. Gene Ther 1999 ; 4 : 606-15.
19. Kaliski A, Maggiorella L, Rouffiac V, Opolon P, Peronneau P, Lassau N, et al. Angiogenic and tumor growth inhibition by an MMP-inhibitor targeting radio-induced MMP-2 and VEGF. Mol Cancer Ther 2005 ; 11 : 1717-28.
20. Escudier B, Lassau N, Couanet D, Angevin E, Mesrati F, Lebourgne S, et al. Phase II trial of thalidomide in renal-cell carcinoma. Ann Oncol 2002 ; 13 : 1029-35.
21. Hochedez P, Lassau N, Bonvalet S, Bidault S, Leclere J, Avril MF. Treatment of local recurrent melanomas by isolated limb perfusion : value of Doppler ultrasonography. J Radiol 2003 ; 84 : 597-603.
22. Lassau N, Lamuraglia M, Vanel D, Le Cesne A, Chami L, Jaziri S, et al. Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas : prospective study of 49 cases. Ann Oncol 2005 ; 16 : 1054-60.
23. Eggermont AM. Evolving imaging technology : contrast-enhanced Doppler ultrasound is early and rapid predictor of tumour response. Ann Oncol 2005 ; 16 : 995-6.
24. Brule A, Lassau N, Perronneau P. Intérêt des données linéaires ultrasonores comparées aux données vidéo dans l'étude de la perfusion tumorale. JFR 2006 ; 87 : 1381.
25. Chami L, Cavalcanti A, Peronneau P, Elie N, Lamuraglia M, Barrani M, et al. Comparaison de méthodes de quantification pour l'évaluation de métastases de mélanomes (MM) traitées par perfusion de membre isolé (ILP) en échographie de contraste (EC). JFR 2006 ; 87 : 1381.
26. Grünhagen DJ, van Etten B, Brunstein F, Graveland WJ, van Geel AN, de Wilt JHW, et al. Efficacy of repeat isolated limb perfusions with tumor necrosis factor and mephalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure. Ann Surg Oncol 2005 ; 12 : 609-15.